RAP1GAP and prostate cancer: In human solid tumors, a polymorphism in the SIPA1 gene causing higher RapGAP activity was associated with high metastatic potential of breast cancer [40], and SIPA1 expression was found to positively correlate with disease progression and metastasis in human prostate cancer [41].